Earnings Per Share, Basic in USD/shares of Seres Therapeutics, Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Seres Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q3 2020 to Q3 2025.
  • Seres Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was 0.94 USD/shares, a 91.9% decline year-over-year.
  • Seres Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 0 USD/shares, a 57.7% decline year-over-year.
  • Seres Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was 0 USD/shares.
  • Seres Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.89 USD/shares, a 61.5% increase from 2022.
  • Seres Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.31 USD/shares, a 221% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Seres Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0.94 -$11 -91.9% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $11.00 -$2 +$2.07 +47.7% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $9.00 $3.76 +$9.25 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $0 -$2 -$1 -481% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 $1.00 $11.60 +$12.00 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 -$10 -$4 -$5 -1306% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 -$5 -$5 -$5 -863% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 $0 $0 +$0.20 +39.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 -$1 $0 +$0.12 +24.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$1 $0.36 +$1.06 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$2 -$1 +$0.04 +6.56% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$2 -$1 +$0.03 +5.56% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-13
Q3 2022 -$2 $0 -$1 -166% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$1 -$1 $0 -32.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $0 -$1 $0 -56.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $0 -$1 Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $0.74 +$1.10 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10

Seres Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 +$0.89 Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 -$1 +$1.42 +61.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 -$2 -$2 -221% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-13
2021 -$1 +$0.40 +35.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 -$1 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.